In recent years, marine natural product bioprospecting has provided key structures and compounds that proved their potential in several fields (human heath, food, cosmetics, veterinary medicine, etc.), particularly as new therepautic agents for a variety of diseases. Most of the marine secondary compounds are still in preclinical or early clinical development process, but some are already on the market, such as cytarabine, or predicted to be approved soon, such as ET743 (YondelisTM).The marine environment also represents a largely unexplored source for isolation of new microbes (bacteria, fungi, etc) that are potent producers of bioactive secondary metabolites. Therefore, this explains why most of the research on marine natural products is in fact search for useful bioactive compounds. The marine organisms will be collected from Turkish water in geographic range and different ecological habitats under the terms of Convention of Biological DiversityThe aim of the project is to identify new natural marine compounds that can serve as lead structures for new products in EU industries. The target fields are drug discovery and cosmetic industry. This project enables Europe to compete with USA and Japan.